U.S. market Closed. Opens in 11 hours 43 minutes

EGRX | Eagle Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-09-302013-09-302012-09-30
Revenue316.61M171.55M187.80M195.89M213.31M236.71M189.48M66.23M19.10M13.68M2.54M
Cost of Revenue94.94M42.18M45.47M60.90M61.92M57.19M55.31M15.65M11.71M7.38M3.17M
Gross Profit221.67M129.37M142.34M135.00M151.40M179.52M134.18M50.58M7.38M6.30M-627.00K
Operating Expenses140.71M126.60M109.38M113.18M104.93M104.02M82.58M48.02M26.14M14.75M19.20M
Selling, General & Admin106.63M75.32M78.60M76.37M60.51M73.07MN/A20.16MN/AN/AN/A
Research & Development34.09M51.27M30.79M36.81M44.42M32.61M30.26M27.86M16.82M9.80M12.80M
Other Operating Expenses-15.75M-6.24M-8.26M700.00K52.23M-1.65M52.31MN/A9.33M4.96M6.40M
Operating Income53.45M-2.91M25.25M21.82M36.62M73.99M51.60M2.56M-18.76M-8.46M-19.83M
Other Expenses / Income7.98M-1.64M-2.58M183.00K-9.85M-1.04M1.83M14.00K-515.00K1.51M-333.00K
Before Tax Income61.43M-4.55M22.68M22.00M34.04M72.94M53.43M2.57M-19.27M-6.95M-20.16M
Income Tax Expenses25.79M4.08M10.69M7.68M2.13M21.00M-28.03M3.00K-1.29M-898.70K-781.00K
Net Income35.64M-8.63M11.99M14.31M31.90M51.94M81.45M2.57M-17.98M-6.05M-19.38M
Interest Expenses4.04M1.64M2.58M2.69M2.74M1.14M8.00K11.00K8.00K1.40M309.00K
Basic Shares Outstanding12.93M13.05M13.48M13.75M14.77M15.10M15.53M15.25M9.96M9.65M10.57M
Diluted Shares Outstanding13.07M13.05M13.77M14.14M15.28M15.91M16.43M16.25M9.96M9.65M10.57M
EBITDA65.48M847.00K30.02M29.34M50.30M77.83M55.02M2.70M-19.16M-5.41M-19.61M
EBITDA Margin20.68%0.49%15.98%14.98%23.58%32.88%29.04%4.07%-100.32%-39.57%-772.55%
EBIT65.48M-2.91M25.25M24.68M36.77M74.08M53.44M2.58M-19.26M-5.55M-19.86M
EBIT Margin20.68%-1.70%13.45%12.60%17.24%31.30%28.20%3.90%-100.86%-40.55%-782.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-09-302013-09-302012-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙